Skip to main content
. 2018 Oct 11;111(3):311–321. doi: 10.1093/jnci/djy142

Figure 6.

Figure 6.

The therapeutic effect of PTC-209 on BC-Pten tumor recurrence. A) Scheme for evaluating the capacity of PTC-209 to inhibit recurrence by tissue recombination strategy. B) H&E images showing the effects of PTC-209 on the growth of recurrent tumors. C) Disease distribution in either vehicle or PTC-209-treated recurrence tumors as assessed by a pathologist. Adeno: Adenocarcinoma, Fisher's exact test. D) Ki67 index in PTC-209 (n = 12)- or vehicle (n = 10)-treated grafts. Data represent the mean ± SD, two-sided Student t test. Scale bar, 50 μm. H&E: hematoxylin and eosin staining.